Drug Information

Drug General Information
Drug ID
D0I4OV
Former ID
DNC010113
Drug Name
(4-(thiophen-2-yl)phenyl)methanamine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530549]
Structure
Download
2D MOL

3D MOL
Formula
C11H11NS
Canonical SMILES
C1=CSC(=C1)C2=CC=C(C=C2)CN
InChI
1S/C11H11NS/c12-8-9-3-5-10(6-4-9)11-2-1-7-13-11/h1-7H,8,12H2
InChIKey
YKNLMMDEWQZCLJ-UHFFFAOYSA-N
PubChem Compound ID
2776332
Target and Pathway
Target(s) Leukotriene A-4 hydrolase Target Info Inhibitor [530549]
BioCyc Pathway Leukotriene biosynthesis
KEGG Pathway Arachidonic acid metabolism
Metabolic pathways
PathWhiz Pathway Arachidonic Acid Metabolism
WikiPathways Arachidonic acid metabolism
Eicosanoid Synthesis
References
Ref 530549J Med Chem. 2010 Jan 28;53(2):573-85.Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesis.
Ref 530549J Med Chem. 2010 Jan 28;53(2):573-85.Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesis.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.